Cyclosporine
Treatment for Interstitial Cystitis
Typical Dosage: 2.5-3.5 mg/kg/day
Effectiveness
70%
Safety Score
35%
Clinical Trials
1
Participants
500
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
35
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-3.5 mg/kg/day
Time to Effect
1-3 months
Treatment Duration
6-12 months, or long-term if tolerated
Evidence Quality
MODERATEConfidence Score
65%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$4,000
Monitoring:$2,400
Side Effect Mgmt:$1,000
Total Annual:$7,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$10,571.43
Cost per Remission
$49,333.33
Cyclosporine Outcomes
for Interstitial Cystitis
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+70%
Remission Rate
+15%
Common Side Effects
Nephrotoxicity
+15%
Hypertension
+15%
Headache
+12%
Gingival hyperplasia
+8%
Increased infection risk
+7%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Cyclosporine in Interstitial Cystitis
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
NCT01990898COMPLETEDPHASE2
26 participants
INTERVENTIONAL
Cleveland, United States
Started: Nov 1, 2013